| CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions |
77 |
| Therapeutic Antisense Oligonucleotides Are Coming of Age |
56 |
| Antibody-Drug Conjugates for Cancer Treatment |
51 |
| Innate Immunity and Neurodegeneration |
47 |
| Entering the Modern Era of Gene Therapy |
45 |
| Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases |
40 |
| Targeting RAGE Signaling in Inflammatory Disease |
39 |
| Novel Latency Reversal Agents for HIV-1 Cure |
33 |
| Treatment of Advanced Prostate Cancer |
32 |
| Gastric Cancer Etiology and Management in Asia and the West |
31 |
| Use and Misuse of Opioids in Chronic Pain |
27 |
| CRISPR Correction of Duchenne Muscular Dystrophy |
27 |
| Clinical Application and Potential of Fecal Microbiota Transplantation |
23 |
| Structure-Based Vaccine Antigen Design |
19 |
| Zika Virus Vaccine Development: Progress in the Face of New Challenges |
18 |
| Long-Acting HIV Drugs for Treatment and Prevention |
17 |
| Lymphedema: Pathogenesis and Novel Therapies |
16 |
| Ethics of Human Genome Editing |
15 |
| Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications |
15 |
| Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology |
14 |
| Circulating Tumor DNA: Measurement and Clinical Utility |
13 |
| New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance |
13 |
| Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis |
13 |
| Emerging Genetic Therapy for Sickle Cell Disease |
13 |
| New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation |
12 |
| Cystic Fibrosis: Emerging Understanding and Therapies |
12 |
| New and Emerging Therapies for Pulmonary Arterial Hypertension |
11 |
| Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical Practice |
11 |
| Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders |
10 |
| DNA Methylation and Susceptibility to Autism Spectrum Disorder |
10 |
| Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics |
10 |
| Recombinant Poliovirus for Cancer Immunotherapy |
10 |
| Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer |
9 |
| New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment |
9 |
| Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes |
9 |
| Active Surveillance as First-Line Management of Papillary Microcarcinoma |
9 |
| Redirected T Cell Cytotoxicity in Cancer Therapy |
9 |
| Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines |
8 |
| Current Status of Living Donor Liver Transplantation in the United States |
8 |
| Measuring Patient-Reported Outcomes: Key Metrics in Reconstructive Surgery |
7 |
| Novel Radiotherapy Techniques for Breast Cancer |
7 |
| Heart Failure with Preserved Ejection Fraction |
7 |
| New Drugs in Multiple Myeloma |
7 |
| PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes |
6 |
| PD-1 Blockade in Early-Stage Lung Cancer |
5 |
| The Global Landscape of Tuberculosis Therapeutics |
4 |
| New Therapeutic Approaches for Familial Hypercholesterolemia |
4 |
| Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention |
4 |
| Risk Stratification for Sudden Cardiac Death After Myocardial Infarction |
4 |
| Understanding Peripartum Cardiomyopathy |
4 |
